| Titolo |
Pubblicato in |
Anno |
| Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosis |
JOURNAL OF NEUROLOGY |
2025 |
| Improvement of measured and perceived disability in overweight patients with Multiple Sclerosis trough different patterns of Mediterranean hypocaloric diet |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2025 |
| Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study |
NEUROTHERAPEUTICS |
2025 |
| Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience |
NEUROTHERAPEUTICS |
2024 |
| Multiple Sclerosis Progression and Relapse Activity in Children |
JAMA NEUROLOGY |
2024 |
| Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis |
JOURNAL OF NEUROLOGY |
2024 |
| Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod |
JOURNAL OF NEUROLOGY |
2024 |
| Brain reserve and timing of clinical onset in multiple sclerosis |
MULTIPLE SCLEROSIS |
2024 |
| Radiological Reporting Systems in Multiple Sclerosis |
APPLIED SCIENCES |
2024 |
| Telerehabilitation and onsite rehabilitation effectively improve quality of life, fatigue, balance, and cognition in people with multiple sclerosis: an interventional study |
FRONTIERS IN NEUROLOGY |
2024 |
| Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off |
SCIENTIFIC REPORTS |
2024 |
| Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS |
BMC NEUROLOGY |
2024 |
| Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2024 |
| COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients |
JOURNAL OF NEUROLOGY |
2024 |
| Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEG |
NEUROBIOLOGY OF DISEASE |
2023 |
| Potential rotective role of pregnancy and breastfeeding in delaying onset symptoms related to multiple sclerosis |
MEDICINA |
2023 |
| Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression |
JOURNAL OF CLINICAL MEDICINE |
2023 |
| The added value of spinal cord lesions to disability accrual in multiple sclerosis |
JOURNAL OF NEUROLOGY |
2023 |
| Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2023 |
| Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case report |
FRONTIERS IN NEUROLOGY |
2023 |
